NLFunding: Strep A/Rheumatic Heart Disease Vaccine Development
Coefficient GivingRemote
Global health and wellbeingGlobal health and infectious diseaseFinance
Why this is on the board
Note: this is not a job but a call for researchers to submit proposals to Coefficient Giving (formerly Open Philanthropy), which funds only around 1 to 2% of unsolicited proposals. The leverage is that there is still no vaccine against Strep A, the bacterium behind rheumatic heart disease in low- and middle-income countries. A single missing piece, such as a better preclinical model or a new antigen, can therefore move the whole development chain forward.
This board is in beta and this is our judgement. If you think we have it wrong, tell us. Give feedback · How we reason about it
About the role
A funding initiative supporting vaccine development projects targeting Strep A and rheumatic heart disease prevention in low- and middle-income countries. - Submit expressions of interest for projects across the vaccine pipeline: Phase 1/CHIM trials, preclinical models, next-generation candidates, or regulatory preparation. - Priority areas include epidemiology and immunology research informing clinical trial design and vaccine timing. - Develop or improve preclinical models, in vitro assays,…
Want to understand this first?
Start with our free course: about 100 minutes in six short units, at your own pace, with no sign-up. To go further, apply for the EA Fellowship: five weeks of reading and discussion in a small group. Also free, but selective.